Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-000534
Filing Date
2025-01-29
Accepted
2025-01-29 15:42:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4738
  Complete submission text file 0001959173-25-000534.txt   6164
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38276 | Film No.: 25569195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014
Business Address
Townsend Adam J. (Reporting) CIK: 0001773588 (see all company filings)

Type: 144